Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ER.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ER.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ER.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ER.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3406.8South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
BA.5.2.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used